Champlain Investment Partners’s Vericel Corp VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
SCM
CCA
VCM
GCM
GKIM
CAM
Champlain Investment Partners's VCEL Position: Q1 2026 in Review
Champlain Investment Partners reduced its Vericel Corp (VCEL) stake by 21% in Q1 2026, selling an estimated $7.59M and leaving 815,173 shares worth $26.2M. The position accounts for 0.33% of the portfolio, ranked #98.
Champlain Investment Partners first reported a position in VCEL in Q4 2024 and has held it in 6 quarters since. The position peaked at $42.4M in Q2 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.
- Champlain Investment Partners held 815,173 shares of Vericel Corp worth $26.2M as of Q1 2026.
- Champlain Investment Partners sold 213,674 Vericel Corp shares in Q1 2026, an estimated $7.59M.
- Vericel Corp made up 0.33% of Champlain Investment Partners's portfolio in Q1 2026, its #98 holding.
- Champlain Investment Partners first reported a position in Vericel Corp in Q4 2024 and has held it in 6 quarters since.
- Champlain Investment Partners's Vericel Corp position peaked at $42.4M in Q2 2025.
- 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.
Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.